{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T05:33:19Z","timestamp":1720675999933},"reference-count":7,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.lpm.2014.08.007","type":"journal-article","created":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T01:59:58Z","timestamp":1412992798000},"page":"1314-1316","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Traiter l\u2019h\u00e9patite C chez des patients usagers de drogue et\/ou pr\u00e9caires\u00a0: \u00e9thique, efficace et utile"],"prefix":"10.1016","volume":"43","author":[{"given":"Andr\u00e9-Jean","family":"Remy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugues","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakim","family":"Bouchkira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2014.08.007_bib0005","first-page":"105","article-title":"\u00c9volution de l\u2019incidence de l\u2019infection par le virus de l\u2019h\u00e9patite C chez les usagers de drogue en France","volume":"19","author":"Lucidarme","year":"2012","journal-title":"Hepatogastro"},{"key":"10.1016\/j.lpm.2014.08.007_bib0010","first-page":"504","article-title":"Estimation de la s\u00e9ropr\u00e9valence du VIH et de l\u2019h\u00e9patite C chez les usagers de drogue en France. Premiers r\u00e9sultats de l\u2019enqu\u00eate ANRS-Coquelicot 2011","volume":"39\u201340","author":"Jauffret-Roustide","year":"2013","journal-title":"BEH"},{"key":"10.1016\/j.lpm.2014.08.007_bib0015","series-title":"Expertise collective Inserm 2010 sur la r\u00e9duction des risques infectieux chez les usagers de drogue","author":"Inserm","year":"2010"},{"key":"10.1016\/j.lpm.2014.08.007_bib0020","series-title":"Circulaire no\u00a0DGS\/MC2\/2008\/79 du 28 f\u00e9vrier 2008 relative \u00e0 la mise en place des centres de soins d\u2019accompagnement et de pr\u00e9vention en addictologie (CSAPA)","author":"DGS","year":"2008"},{"key":"10.1016\/j.lpm.2014.08.007_bib0025","series-title":"Prise en charge des personnes infect\u00e9es par les virus de l\u2019h\u00e9patite B et ou de l\u2019h\u00e9patite C\u00a0: rapport de recommandations 2014 ANRS AFEF","author":"RF","year":"2014"},{"key":"10.1016\/j.lpm.2014.08.007_bib0030","series-title":"Place des tests rapides d\u2019orientation diagnostique (TROD) dans la strat\u00e9gie de d\u00e9pistage de l\u2019h\u00e9patite C.","author":"HAS","year":"2013"},{"key":"10.1016\/j.lpm.2014.08.007_bib0035","series-title":"Hepatitis mobile team: a new concept for benefit toward drugs users with hepatitis C and outside social and medical teams. 11th European Congress on heroin addiction and related clinical problems","author":"Remy Aj","year":"2014"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214004606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214004606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T12:56:58Z","timestamp":1538139418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498214004606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":7,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0755498214004606"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2014.08.007","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traiter l\u2019h\u00e9patite C chez des patients usagers de drogue et\/ou pr\u00e9caires\u00a0: \u00e9thique, efficace et utile","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}